Acanthamoeba keratitis

International Ophthalmology Clinics

Volumn 47, Issue 2, 2007, Pages 33-46

  Chong, Eva Marie ^a   Dana, M Reza ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIAMEBIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CHLORHEXIDINE; DESMODINE; HEXAMIDINE; IMIDAZOLE; ITRACONAZOLE; METFORMIN; METRONIDAZOLE; MILTEFOSINE; NEOMYCIN; OFLOXACIN; PHENFORMIN; PHOSPHOLIPASE; POLY(HEXAMETHYLENEBIGUANIDE); PROPAMIDINE; PROPAMIDINE ISETHIONATE; STEROID; UNCLASSIFIED DRUG; VORICONAZOLE;

ACANTHAMOEBA; ACANTHAMOEBA CASTELLANII; ACANTHAMOEBA KERATITIS; CONTACT LENS; CORYNEBACTERIUM XEROSIS; CULTURE TECHNIQUE; DIAGNOSTIC PROCEDURE; ENDOPHTHALMITIS; EYE SURGERY; HUMAN; IMMUNOPROPHYLAXIS; LIFE CYCLE; MEDICAL TECHNOLOGY; MICROORGANISM; MICROSCOPY; MOLECULAR PROBE; MONOTHERAPY; NONHUMAN; ORBIT GRANULOMA; ORBIT INJURY; PATHOGENICITY; PATIENT EDUCATION; PERSONAL HYGIENE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUBSPECIES; UVEITIS;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ANIMALS; HUMANS; RISK FACTORS;

EID: 34248165993     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e318036bcf4     Document Type: Review

References (51)

1. Puschkarew B. Uber die Verbreitugen der Susswasserprotozoen durch die Luft. Arch Protistenkd BD. 1913;23:323-362.,
2. reference cited in: Larkin DF. Acanthamoeba keratitis. Int Ophthalmol Clin. 1991;31:163-172.
3. Auran JD, Starr MB, Jakobiec FA. Acanthamoeba keratitis. A review of the literature. Cornea. 1987;6:2-26. Review.
4. Rumelt S, Cohen I, Lefler E, et al. Corneal co-infection with Scedosporium apiospermum and Acanthamoeba after sewage-contaminated ocular injury. Cornea. 2001;20:112-116.
5. Pussard M, Pons R. Morphologies de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida). Protistologica. 1977;13:557-610.,
6. as cited in reference of article by Illingworth CD, Cook SD. Acanthamoeba keratitis. Surv Ophthalmol. 1998;42:493-508.
7. Khan NA, Jarroll EL, Paget TA. Molecular and physiological differentiation between pathogenic and nonpathogenic Acanthamoeba. Curr Microbiol. 2002;45:197-202.
8. Hurt M, Neelam S, Niederkorn J, et al. Patogenic Acanthamoeba spp. secrete a mannose-induced cytolytic protein that correlates with the ability to cause disease. Infect Immun. 2003;71:6243-6255.
9. Na BK, Kim JC, Song CY. Charaterization and pathogenetic role of proteinase from Acanthamoeba castellani. Microb Pathogenesis. 2001;30:39-48.
10. Hurt M, Proy V, Niederkorn JY, et al. The interaction of Acanthamoeba castellani cysts with macrophages and neutrophils. J Parasitol. 2003;89:565-572.
11. Kilvington S, Gray T, Dart J, et al. Acanthamoeba keratitis: The role of domestic tap water contamination in the United Kingdom. Invest Ophalmol Vis Sci. 2004;45:165-169.
12. Seal DV. Acanthamoeba keratitis update - incidence, molecular epidemiology and new drugs for treatment. Eye. 2003;17:893-905.
13. Jones DB, Robinsson NR, Visvescara GS. Paper presented at the ocular microbiology and immunology group meeting, Dallas, Texas; September, 1973.
14. Cited in Jones DB, Visvesvara GS, Robinson NR, Acanthamoeba polyphagia keratis and Acanthamoeba uvetis associated with fatal meningoencephalitis. Trans Ophthalmol Soc UK. 1975;95:221-232.
15. Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol. 1989;107:331-336.
16. Schaumberg DA, Snow KK, Dana MR. The Epidemic of Acanthamoeba keratitis: where do we stand? Cornea. 1998;17:3-10.
17. Pasricha G, Harma S, Garg P, et al. Use of 18S rRNA gene-based PCR assay for diagnosis of Acanthamoeba keratitis in non-contact lens wearers in India. J Clin Microbiol. 2003;41:3206-3211.
18. Lam DS, Houang E, Fan DS, et al., Hong Kong Microbial Keratitis Study Group. Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye. 2002;16:608-618.
19. Radford CF, Minassian DC, Dart JK. Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol. 2002;86:536-542.
20. Beattie TK, Tomlinson A, McFadyen AK. Attachment of Acanthamoeba to first- and second-generation silicone hydrogel contact lenses. Ophthalmology. 2006;113:117-125.
21. Sun X, Zhang Y, Li R, et al. Acanthamoeba keratitis. Clinical characteristics and management. Ophthalmology. 2006;113:412-416.
22. Wilhelmus KR. Acanthamoeba keratitis during orthokeratology. Cornea. 2005;24:864-866.
23. Schein OD. Microbial keratitis associated with overnight orthokeratology. What we need to know. Cornea. 2005;24:767-769.
24. Alizadeh H, Apte S, El-Agha MS, et al. Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea. 2001;20:622-627.
25. Hurt M, Apte S, Leher H, et al. Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antiboides. Infect Immun. 2001;69:2988-2995.
26. Clarke DW, Alizadeh H, Niederkorn JY. Failure of Acanthamoeba castellani to produce intraocular infections. Invest Ophthalmol Vis Sci. 2005;46:2472-2478.
27. Leher HF, Alizadeh H, Taylor WM, et al. Role of mucosal IgA in the resistance to Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1998;39:2666-2673.
28. Lee GA, Gray TB, Dart JK, et al. Acanthamoeba sclerokeratitis. Ophthalmology. 2002;109:1178-1182.
29. Claerhout I, Goegebuer A, Van Den Broecke C, et al. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefe's Arch Clin Exp Ophthalmol. 2004;242:648-653.
30. Bacon AS, Frazer DG, Dart JKG, et al. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye. 1993;7:719-725.
31. Wilhelmus KR, Osato MS, Font RL, et al. Rapid diagnosis of Acanthamoeba keratitis using calcofluor white. Arch Ophthalmol. 1986;104:1309-1312.
32. Grossniklaus HE, Waring GO IV, Akor C, et al. Evaluation of hemotoxylin and eosin and special stains for the detection of acanthamoeba kratitis in penetrating keratoplasties. Am J Ophthamol. 2003;136:520-526.
33. Pfister DR, Cameron JD, Krachmer JH, et al. Confocal microscopy findings of Acanthamoeba keratitis. Am J Ophthalmol. 1996;121:119-128.
34. Radford CF, Minasian DC, Dart JK. Acanthamoeba keratitis in England and Wales: incidence, outcome and risk factors. Br J Ophthalmol. 2002;86:536-542.
35. Parmar DN, Awwad ST, Petroll WM, et al. Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis. Ophthalmology. 2006;113:538-547.
36. Lehmann OJ, Green SM, Morlet N, et al. Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1998;39:1261-1265.
37. Khunkitti W, Hann AC, Lloyd D, et al. Biguanide-induced changes in Acanthamoeba castellani: an electron microscopic study. J Appl Microbiol. 1998;84:53-62.
38. Hargrave SL, McCulley JP, Husseini Z. Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group. Ophthalmology. 1999;106:952-957.
39. Elder MJ, Kilvingto S, Dart JKG. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophtalmol Vis Sci. 1994;35:1059-1064.
40. Ishibashi Y, Matsumoto Y, Kabata T, et al. Oral itraconazole and topical miconazole with debridement for Acanthamoeba keratitis. Am J Ophthalmol. 1990;109:121-126.
41. McClellan K, Howard K, Niederkorn JY, et al. Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci. 2001;42:2885-2893.
42. Hurt M, Howard K, Cavanagh HD, et al. Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea. 2001;20:622-627.
43. Park DH, Palay DA, Daya SM, et al. The role of topical corticosteroids in the management of Acanthamoeba keratitis. Cornea. 1997;16:277-283.
44. Perez-Santonja JJ, Kilvington S, Hughes R, et al. Persistently culture positive Acanthamoeba Keratitis. In vivo resistance and in vitro sensitivity. Ophthalmology. 2003;110:1593-1600.
45. Ficker LA, Kirkness C, Wright P. Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology. 1993;100:105-110.
46. Moshari A, McLean IW, Dodds MT, et al. Chorioretinitis after keratitis caused by Acanthamoeba case report and review of the literature. Ophthamology. 2001;108:2232-2236.
47. Yang YF, Matheson M, Dart JK, et al. Persistence of acanthamoeba antigen following acanthamoeba keratitis. Br J Ophthalmol. 2001;85:277-280.
48. Herz N, Matoba AY, Jones DB, et al. Rapidly Progressive Cataract and Iris Atrophy During Treatment of Acanthamoeba Keratitis. San Francisco, CA: ASCRS Poster P103; 2006.
49. Binder PS. Cryotherapy for medically unresponsive acanthamoeba keratitis. Cornea. 1989;8:106-114.
50. Jeong HJ, Yu HS. The role of domestic tap water in Acanthamoeba contamination in contact lens storage cases in Korea. Korean J Parasitol. 2005;43:47-50.
51. Hiti K, Walochnik J, Faschinger C, et al. Microwave treatment of contact lens cases contaminated with Acanthamoeba. Cornea. 2001;20:467-470.